Overview
Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)
Status:
Completed
Completed
Trial end date:
2004-06-30
2004-06-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
A study to evaluate the effects of combination losartan versus combination atenolol in patients with ambulatory systolic hypertension.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Merck Sharp & Dohme Corp.Treatments:
Amlodipine
Atenolol
Hydrochlorothiazide
Losartan
Criteria
Inclusion Criteria:- Males or females at least 18 years of age who have ambulatory systolic hypertension.